Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients
Open Access
- 14 January 2017
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 140 (3), 710-719
- https://doi.org/10.1016/j.jaci.2016.11.038
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Insights into Group 2 Innate Lymphoid Cells in Human Airway DiseaseCurrent Allergy and Asthma Reports, 2016
- Type 2 inflammation in asthma — present in most, absent in manyNature Reviews Immunology, 2014
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic AsthmaThe New England Journal of Medicine, 2014
- Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthmaJournal of Allergy and Clinical Immunology, 2013
- Dupilumab in Persistent Asthma with Elevated Eosinophil LevelsThe New England Journal of Medicine, 2013
- Exploring the Effects of Omalizumab in Allergic AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2013
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroidsProceedings of the National Academy of Sciences of the United States of America, 2007
- Factors Influencing the Responsiveness to Inhaled Glucocorticoids of Patients With Moderate-to-Severe AsthmaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2005
- Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthmaThorax, 2000